Novo Nordisk enters bidding war with Pfizer
Digest more
Novo Nordisk A/S (NYSE:NVO) is one of the Best Bargain Stocks to Buy in November. On October 22, Reuters reported that Novo Nordisk A/S (NYSE:NVO)’s top investor, the non-profit Novo Nordisk ...
The chairman of Novo Nordisk and six other independent board members quit on Tuesday after a dispute with the company's ...
Costco is now selling the pricey blockbuster weight-loss drugs Wegovy and Ozempic at discounted prices. The Danish drugmaker Novo Nordisk said Monday the medications cost $499 at Costco ...
Novo Nordisk Shares Fell 5.6% After President Trump Commented on Future Price Cuts for Weight Loss Drugs. Should Investors Be Worried? It's not the end of the world for the drugmaker.
Novo Nordisk (NVO) recruits top healthcare analyst Michael Novod, a long time bull of the company, as head of its investor ...
Novo Nordisk today announced plans to present 11 abstracts at the 76th Annual American Association for the Study of Liver ...
Novo Nordisk (($NVO)) announced an update on their ongoing clinical study. Study Overview: Novo Nordisk is conducting a study titled ‘Wegovy® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback